Alessandro Vannini elected EMBO member
The European Molecular Biology Organisation (EMBO) is an organization of more than 2,000 leading researchers that promotes excellence in the life sciences in Europe and beyond. Every year outstanding researchers around the world are given the opportunity to join the community as EMBO members. This is a lifelong honour for distinguished scientists who have made important contributions to the life sciences over the course of their careers.
Among the 69 new EMBO members announced today is Alessandro Vannini, Head of the Structural Biology Research Centre at Human Technopole.
Alessandro was the first Head of Research Centre and Group Leader to join Human Technopole in September 2019, when the institute was still in the very early stages of development. He moved to Milan from London where he previously worked as Principal Investigator and Deputy Head of Division at the Institute of Cancer Research in London. Over the past four years he has built up the Structural Biology Research Centre, which now includes five research groups and 45 active researchers.
When hearing about his election as EMBO member, Alessandro noted: “What an incredible honour to be elected EMBO Member and become a part of such an inspirational group of scientists. I am very grateful for EMBO support throughout the years, from being an EMBO Postdoctoral fellow to then becoming an EMBO Young Investigator. These programmes played a truly important role in shaping my career as a scientist. Being elected an EMBO Member now means coming full circle and I am looking forward to being part of this fantastic community.”
About EMBO membership
EMBO members can actively participate in EMBO’s initiatives by serving on the organisation’s Council, committees and editorial boards, participating in the evaluation of applications for EMBO funding, acting as mentors to young scientists in our community, and advising on key activities. EMBO members also have the privilege to nominate and elect candidates for EMBO membership, for Council and for the EMBO Gold Medal.
Learn more: www.embo.org/members.html
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.